CDKN2A and acute lymphoblastic leukemia: In ALL Cdkn2a is a tumor suppressor involved in cell cycle regulation18,19, and in our disease model there was an acute response to the disease during the early stages of leukemia development, but this response was attenuated as the disease progressed.